Skip to content
naulon
Not checkedNot checked for notices yet.

Developing tissue engineering strategies for liver regeneration

Jinglin Wang, Danqing Huang, Hang Yu and 3 more

Engineered Regeneration · 2022

doi:10.1016/j.engreg.2022.02.003 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

The regenerative function of liver can be destroyed by viral infection, drug poisoning and tumorigenesis, resulting in irreversible damage. Numerous approaches in promoting liver repair intend to replace liver transplantation, which is faced with a shortage of donors. Owing to the significant advantages in cell programming and bioscaffold engineering, liver tissue engineering is considered to be the most promising alternative for mimicking liver microstructure, maintaining hepatic function or implanting whole liver. Cell sources gradually develop from primary hepatocytes, tumor cells, stem cell-induced cells to multiple cell coculture formats, spheroids and organoids, which have realized the improvement of cell function, overcome the problem of large-scale cell expansion and avoid the risk of immune rejection. Scaffolds, biocompatible materials are applied as cell carriers, and decellularized scaffolds and three-dimensional bioprinting liver pipeline structures are also used to accelerate cell colonization and proliferation. We enumerate sufficient research concerning liver tissue engineering in this review, including single and multiple cell sources, implantable and extracorporeal scaffold materials, and so on, providing critical conclusions and future implications of tissue engineering in liver regenerative applications.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.